FLT3 and acute myeloid leukemia: To evaluate the translational relevance of MA49, we assessed how MA49, MA68, sorafenib, MA72, and the clinically used chemotherapeutic cytarabine affected primary AML patient samples with FLT3 or FLT3-ITD.